Trial Profile

CUSTOM-III

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Oct 2008

At a glance

  • Drugs Umirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Registrational; Therapeutic Use
  • Acronyms CUSTOM-III
  • Sponsors Xtent
  • Most Recent Events

    • 13 Oct 2008 One-year data presented at the Transcatheter Cardiovascular Therapeutics meeting.
    • 13 May 2008 Positive six-month follow-up data were presented at the annual EuroPCR meeting in May.
    • 25 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top